Clinical Trials
Active studies & trials
Registry participants may be eligible for clinical trials testing new treatments for bronchiectasis and NTM. Explore active studies and learn how to participate.
Recruiting
Active clinical trials
Brensocatib Study
This Phase 3 trial is evaluating brensocatib, a potential first FDA-approved treatment for bronchiectasis. The study examines the drug's effectiveness in reducing exacerbations and improving quality of life.
Insmed Incorporated
Actively Recruiting
Calgary, AB + Multiple Sites
Join the Registry
Your participation advances research
By joining our registry, you contribute to groundbreaking research that could lead to new treatments and better outcomes for thousands of patients.
Eligibility Criteria
Inclusion Criteria
- Adults over the age of 18
- Diagnosis of non-CF bronchiectasis
- Diagnosis of Nontuberculous Mycobacteria (NTM)
Exclusion Criteria
- Under the age of 18
- Cystic fibrosis-related bronchiectasis
How to Enroll
Contact Our Team
Reach out to our research coordinators to express interest and ask questions.
Eligibility Review
Our team will review your medical history to confirm eligibility criteria.
Informed Consent
Review and sign the consent form after discussing the study with our team.
Begin Participation
Complete initial assessments and begin contributing to vital research.
Ready to participate?
Join the registry or get in touch
Have questions about eligibility, trials, or the enrollment process? Our team is here to help.